Svetlana Dambaeva

Dr. Svetlana Dambaeva

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2017 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
YGYekaterina Galat
Yekaterina Galat
SDSvetlana Dambaeva
Svetlana Dambaeva
IEIrina Elcheva
Irina Elcheva
AKAaruni Khanolkar
Aaruni Khanolkar
KBKenneth Beaman
Kenneth Beaman
VGVasiliy Galat
Vasiliy Galat
The robust generation of human hematopoietic progenitor cells from induced or embryonic pluripotent stem cells would be beneficial for multiple areas of research, including mechanistic studies of hematopoiesis, the development of cellular therapies for autoimmune diseases, induced transplant tolerance, anticancer immunotherapies, disease modeling, and drug/toxicity screening. Over the past years, significant progress has been made in identifying effective protocols for hematopoietic differentiation from pluripotent stem cells and understanding stages of mesodermal, endothelial, and hematopoietic specification. Thus, it has been shown that variations in cytokine and inhibitory molecule treatments in the first few days of hematopoietic differentiation define primitive versus definitive potential of produced hematopoietic progenitor cells. The majority of current feeder-free, defined systems for hematopoietic induction from pluripotent stem cells include prolonged incubations with various cytokines that make the differentiation process complex and time consuming. We established that the application of Wnt agonist CHIR99021 efficiently promotes differentiation of human pluripotent stem cells in the absence of any hematopoietic cytokines to the stage of hemogenic endothelium capable of definitive hematopoiesis. The hemogenic endothelium differentiation was accomplished in an adherent, serum-free culture system by applying CHIR99021. Hemogenic endothelium progenitor cells were isolated on day 5 of differentiation and evaluated for their endothelial, myeloid, and lymphoid potential. Monolayer induction based on GSK3 inhibition, described here, yielded a large number of CD31+CD34+ hemogenic endothelium cells. When isolated and propagated in adherent conditions, these progenitors gave rise to mature endothelium. When further cocultured with OP9 mouse stromal cells, these progenitors gave rise to various cells of myeloid lineages as well as natural killer lymphoid, T-lymphoid, and B-lymphoid cells. The results of this study substantiate a method that significantly reduces the complexity of current protocols for hematopoietic induction, offers a defined system to study the factors that affect the early stages of hematopoiesis, and provides a new route of lymphoid and myeloid cell derivation from human pluripotent stem cells, thus enhancing their use in translational medicine.

21 February 2020 in American Journal of Reproductive Immunology
Verified
Journal Article
Closed access
PDF file
WWWenjuan Wang
Wenjuan Wang
MGMaria Dinorah Salazar Garcia
Maria Dinorah Salazar Garcia
GDGloria Deutsch
Gloria Deutsch
NSNayoung Sung
Nayoung Sung
XYXiuhua Yang
Xiuhua Yang
JKJoanne Kwak-Kim
Joanne Kwak-Kim

5 January 2018 in Biology of Reproduction
Verified
Journal Article
Open access
PDF file
SDSvetlana Dambaeva
Svetlana Dambaeva
SSSylvia Schneiderman
Sylvia Schneiderman
MJMukesh K Jaiswal
Mukesh K Jaiswal
VAVarkha Agrawal
Varkha Agrawal
GKGajendra K Katara
Gajendra K Katara
KBKenneth D Beaman
Kenneth D Beaman
Preterm birth is widespread and causes 35% of all neonatal deaths. Infants who survive face potential long-term complications. A major contributing factor of preterm birth is infection. We investigated the role of interleukin 22 (IL22) as a potential clinically relevant cytokine during gestational infection. IL22 is an effector molecule secreted by immune cells. While the expression of IL22 was reported in normal nonpregnant endometrium and early pregnancy decidua, little is known about uterine IL22 expression during mid or late gestational stages of pregnancy. Since IL22 has been shown to be an essential mediator in epithelial regeneration and wound repair, we investigated the potential role of IL22 during defense against an inflammatory response at the maternal–fetal interface. We used a well-established model to study infection and infection-associated inflammation during preterm birth in the mouse. We have shown that IL22 is upregulated to respond to an intrauterine lipopolysaccharide administration and plays an important role in controlling the risk of inflammation-induced preterm birth. This paper proposes IL22 as a treatment method to combat infection and prevent preterm birth in susceptible patients.

1 September 2014 in Fertility and Sterility
Verified
Journal Article
Closed access
KOKuniaki Ota
Kuniaki Ota
SYSho-Ichi Yamagishi
Sho-Ichi Yamagishi
MKMichael Kim
Michael Kim
SDSvetlana Dambaeva
Svetlana Dambaeva
AGAlice Gilman-Sachs
Alice Gilman-Sachs
JKJoanne Kwak-Kim
Joanne Kwak-Kim

1 June 2017 in Gynecologic Oncology
Verified
Journal Article
Closed access
KBKenneth D. Beaman
Kenneth D. Beaman
SDSvetlana Dambaeva
Svetlana Dambaeva
GKGajendra K. Katara
Gajendra K. Katara
AKArpita Kulshrestha
Arpita Kulshrestha
AGAlice Gilman-Sachs
Alice Gilman-Sachs

31 January 2011 in American Journal of Reproductive Immunology
Verified
Journal Article
Open access
PDF file
ARAnn E. Rozner
Ann E. Rozner
SDSvetlana Dambaeva
Svetlana Dambaeva
JDJessica G. Drenzek
Jessica G. Drenzek
MDMaureen Durning
Maureen Durning
TGThaddeus G. Golos
Thaddeus G. Golos
Citation Rozner AE, Dambaeva SV, Drenzek JG, Durning M, Golos TG. Modulation of cytokine and chemokine secretions in rhesus monkey trophoblast co‐culture with decidual but not peripheral blood monocyte–derived macrophages. Am J Reprod Immunol 2011; 66: 115–127Problem  Decidual macrophages are thought to promote pregnancy success, in part through interactions with invading trophoblast cells in hemochorial placentation. However, the factors that constitute this regulatory cross talk are not well understood.Method of study  Rhesus monkey decidual and peripheral blood–derived macrophages were co‐cultured with primary Rhesus trophoblasts. Macrophage functions including cell‐surface marker expression, antigen uptake and processing, in vitro migration, and cytokine and chemokine secretions were evaluated.Results  While most macrophage functions were unchanged by trophoblast co‐culture, changes in the secretion of selected cytokines and the migration of trophoblasts were noted when decidual (but generally, not peripheral blood monocyte–derived) macrophages were cultured with trophoblasts. In addition, basal secretion differed significantly between peripheral blood–derived and decidual macrophages for a broad spectrum of cytokines. When trophoblasts were pre‐treated with an anti‐Mamu‐AG antibody, 25D3, there was no change in cytokine or chemokine secretion.Conclusion  Macrophage cytokine expression can be modulated by trophoblast co‐culture, but it remains unclear how Mamu‐AG is involved.